7/1/2022Solasia to Slash 65% of Workforce in China as It Transfers Core Distri...

7/1/2022ReNeuron Signs Supplemental Supply Deal with Shanghai Fosun Pharma

7/1/2022Eurofins DiscoverX Establishes A New China Biotechnology Office

6/30/2022NMPA Issues the List of Reference Formulations for GQCE Studies (55th ...

6/29/2022WuXi STA Opens Another High-Potency API Plant In Changzhou

6/29/2022NMPA Issues the Implementation Plans for Manufacture by Hong Kong and ...

6/29/2022Nature: Unleashing the Power of Big Data to Guide Precision Medicine i...

6/28/2022China Speeds Up Smooth Execution Of Patent Open License System

6/28/2022CDE Solicits Comments on the Draft Technical Guidelines for Clinical E...

6/28/2022NMPA Holds Symposium on Trials of Drug Real World Clinical Data Applic...

6/28/2022NMPA Issues Notice to Further Strengthen Services to Foreign-Invested ...

6/28/2022BioLineRx and GenFleet Agree to Further Develop Motixafortide in PDAC...

6/28/2022Palleon and Henlius Enter into Strategic Collaboration to Develop Bifu...

6/27/2022NMPA Issues Three New Documents on Drug Tracing and Vaccine Production...

6/27/2022CDE Solicits Comments on the Draft Technical Guidelines for Clinical R...

6/27/2022Snapshot of Patient Expenditures of Level II and Above Public Hospital...

6/27/2022Amgen Strikes Outliciensing Deal with Fosun for Otezla and Parsabiv in...

6/27/2022Zai Lab Announces Primary Listing on the Main Board of HKEx

6/27/2022Antengene Enters Clinical Partnership with BeiGene to Evaluate Selinex...

6/24/2022CDE's Annual Review of Chinese Drug Evaluation & Registration in 2021 ...

6/24/2022Drug R&D and Product Registration News Digest June 2022 (3)

6/24/2022Huadong and Julphar Announce Strategic Cooperation of Liraglutide in M...

6/24/2022At ASCO 2022, Chinese Biotech Firms Deliver Rosy Data On PD-(L)1, Cell...

6/23/2022The Great Wall: Why Overseas Sponsors Are Yet to Fully Tap into China'...

6/23/2022Sino Biopharmaceutical to Acquire F-Star Therapeutics for $161M

6/23/2022NMPA Announces Package Insert Revision of Glucosamine Formulations

6/23/2022CDE Issues the Technical Guidelines for Protocol Changes During Clinic...

6/23/2022GlobalData: Borrena (lorlatinib) Approval Further Strengthens Pfizer P...

6/23/2022Deloitte Maps Out Four Likely Scenarios for China's Health Ecosystem i...

6/22/2022CDE Solicits Comments on Three Draft Technical Guidelines for Bioequiv...

Page:135/774 Total number of articles:23208: [First][<<] [133] [134] [135] [136] [137] [>>] [End]